Skip to content

The effects of different early enteral nutrition regimens on clinical and physiological indicators of patients with severe pneumonia: A prospective controlled study

The effects of different early enteral nutrition regimens on clinical and physiological indicators of patients with severe pneumonia: A prospective controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120103
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Pneumonia

Interventions

Severe Pneumonia Observation Group:None

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Use enteral nutrition as the main feeding method (the energy provided by enteral nutrition is greater than that from parenteral nutrition); 2. Insert a gastric tube, nasojejunal tube, or perform a gastrostomy, and the enteral nutrition is administered smoothly; 3. The patient or the family member is informed and signs the consent form; 4. Meet the diagnostic criteria for severe pneumonia, and the diagnostic criteria typically rely on a series of clinical indicators. According to the "American IDSA/ATS Guidelines", they are divided into primary criteria and secondary criteria. Meeting one primary criterion or >= 3 secondary criteria is sufficient; 5. There is a risk of malnutrition in the nutritional screening (NRS 2002 >= 3 points), and there are indications for nutritional support treatment.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of allergy to any component of enteral nutrition formulas; 2.Patients with severe cardiac, hepatic, or renal dysfunction, or with significant disturbances in internal homeostasis; 3.Patients with severe diabetes or those receiving high-dose corticosteroid therapy; 4.Pregnant or lactating women; 5.Patients with disorders of amino acid metabolism; 6.Patients with uncontrolled shock, hemodynamic instability, or inadequate tissue perfusion; 7.Patients with uncontrolled life-threatening hypoxemia, hypercapnia, or acidosis; 8.Patients with active upper gastrointestinal bleeding, significant gastrointestinal ischemia, high-output small intestinal fistula, or abdominal compartment syndrome; 9.Patients with gastrointestinal decompression drainage exceeding 500 mL per 6 hours; 10.Patients deemed unsuitable for participation by the clinical care team.

Design outcomes

Primary

MeasureTime frame
Changes in diaphragm function;

Secondary

MeasureTime frame
Changes in muscle strength of the limbs;Intestinal barrier function indicators;Nutritional indicators;Inflammatory indicators;Immune indicators;Severity score of the disease;

Countries

China

Contacts

Public ContactLei Shu

Zhejiang Provincial Hospital of Traditional Chinese Medicine

13588132236@163.com+86 571 8662 0356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026